New pill could ease severe eczema itch and rash

NCT ID NCT07216027

Recruiting now Symptom relief Sponsor: Pfizer Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests an experimental daily tablet (PF-08049820) for adults with moderate to severe eczema (atopic dermatitis). About 165 participants will take either the study drug or a placebo for 12 weeks. Researchers will check skin improvement, itching, and safety through clinic visits and tests. The goal is to see if the drug can reduce symptoms like rash and severe itching.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atopic eczema Eczema

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ATOPIC DERMATITIS ECZEMA, ATOPIC

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Clinical Science Institute
RECRUITING

Santa Monica, California, 90404, United States
Dermatology and Ophthalmology Kume Clinic
NOT_YET_RECRUITING

Sakai, Osaka, 593-8324, Japan
Fukuwa Clinic
NOT_YET_RECRUITING

Chuo-ku, Tokyo, 104-0031, Japan
Gsi Clinical Research
NOT_YET_RECRUITING

Margate, Florida, 33063, United States
Hattori Dermatology Clinic
NOT_YET_RECRUITING

Takasaki, Gunma, 370-0071, Japan
Kosugi Dermatology Clinic
NOT_YET_RECRUITING

Kawasaki-shi, Kanagawa, 211-0063, Japan
Nihonbashi Sakura Clinic
NOT_YET_RECRUITING

Chuo-ku, Tokyo, 103-0025, Japan
Northridge Clinical Trials
RECRUITING

Northridge, California, 91325, United States
Queen's Square Medical Facilities
NOT_YET_RECRUITING

Yokohama, Kanagawa, 220-6208, Japan
Skin Research of South Florida
ACTIVE_NOT_RECRUITING

Miami, Florida, 33173, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.